|1.||Jin, Wei: 3 articles (01/2014 - 01/2010)|
|2.||Jiang, Jian: 3 articles (01/2014 - 01/2010)|
|3.||Wang, Handong: 3 articles (01/2014 - 01/2010)|
|4.||Ni, Hongbin: 3 articles (01/2014 - 01/2010)|
|5.||Liang, Weibang: 3 articles (01/2014 - 01/2010)|
|6.||Li, Jiang: 3 articles (02/2005 - 01/2002)|
|7.||Johnson, Jeffrey A: 3 articles (02/2004 - 01/2002)|
|8.||Johnson, J A: 3 articles (06/2001 - 07/2000)|
|9.||Li, Tao: 2 articles (09/2015 - 05/2014)|
|10.||Lu, Xin-Yu: 2 articles (09/2015 - 05/2014)|
|1.||Brain Injuries (Brain Injury)
09/01/2015 - "The aim of this study was to explore the effect of tBHQ treatment on early stage brain injury at 24 h after SAH. "
05/01/2014 - "Pretreatment with tert-butylhydroquinone attenuates cerebral oxidative stress in mice after traumatic brain injury."
10/25/2012 - "The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury."
07/01/2011 - "Protective effect of tert-butylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice."
01/01/2010 - "Effects of tert-butylhydroquinone on intestinal inflammatory response and apoptosis following traumatic brain injury in mice."
04/08/2002 - "Concurrent alpha-Toc, TBHQ or PG treatment with NaNO2 is likely to induce forestomach tumors in the long term."
01/01/1988 - "Mammary tumor development was reduced by diet containing TMPD, PG, TBMP, TBHQ or GG, although this could be partly due to antioxidant treatment-associated decrease in body wt gain. "
02/01/2013 - "Much of the funding has led to (1) the novel discovery that arsenic activates the Nrf2 pathway by a mechanism different to that of other Nrf2 activators, such as sulforaphane and tert-butylhydroquinone, (2) activation of Nrf2 by chemopreventive compounds protects against arsenic toxicity and carcinogenicity both in vitro and in vivo, (3) constitutive activation of Nrf2 by disrupting Keap1-mediated negative regulation contributes to cancer and chemoresistance, (4) p62-mediated sequestration of Keap1 activates the Nrf2 pathway, and (5) arsenic-mediated Nrf2 activation may be through a p62-dependent mechanism. "
05/23/1995 - "Interestingly, AP-1 DNA binding activity was induced by the phenolic antioxidant tert-butylhydroquinone (BHQ), but the induction of AP-1 transcriptional activity by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) was inhibited by this compound. "
06/01/2008 - "Upregulation of Nrf2 by the small chemical tert-butylhydroquinone (tBHQ) also enhanced the resistance of cancer cells, indicating the feasibility of using small chemical inhibitors of Nrf2 as adjuvants to chemotherapy to increase the efficacy of chemotherapeutic agents. "
|3.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/01/2015 - "Tert-butylhydroquinone Ameliorates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Mice by Enhancing Nrf2-Independent Autophagy."
01/01/2014 - "Tert-butylhydroquinone alleviates early brain injury and cognitive dysfunction after experimental subarachnoid hemorrhage: role of Keap1/Nrf2/ARE pathway."
02/01/2005 - "Taken together, this study suggests that identified antioxidant genes, which were upregulated through tBHQ induced Nrf2 stabilization, confer protection on target cells against H2O2-induced apoptotic cell death in neuroblastoma cells as well as the necrotic cell death in the hNSC. "
11/26/2003 - "Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells."
01/01/2002 - "Gene expression induced by tBHQ (10 microM) in IMR-32 human neuroblastoma cells was analyzed by means of large-scale oligonucleotide microarray. "
01/12/2001 - "Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells."
03/01/1999 - "Furthermore, activation of the hQR-ARE/EpRE by tBHQ correlates with induction of endogenous QR activity in IMR-32 neuroblastoma cells (15-fold). "
09/01/2007 - "In this study, we investigated the neuroprotective effect of tBHQ against deltamethrin (DM)-induced oxidative stress using rat PC12 adrenal pheochromocytoma cells. "
10/01/2015 - "The present study aimed to investigate the possible neuroprotective role of tert-butylhydroquinone (tBHQ), a general Nrf2 activator, on sodium fluoride (NaF)-induced oxidation damage and apoptosis in neuron-like rat pheochromocytoma (PC12) cells. "
|2.||Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
|5.||Estrogen Receptor Modulators (Antiestrogen)
|6.||Protein Isoforms (Isoforms)
|7.||Oxidopamine (6 Hydroxydopamine)
|8.||Glucuronosyltransferase (UDP Glucuronosyltransferase)
|9.||Sodium Fluoride (Ossin)
|1.||Drug Therapy (Chemotherapy)